Skip to content
Use caution Drug recall · FDA · Published July 7, 2020

Mylan Daptomycin Injection Recall: Particulate Matter Hazard

Mylan recalls Daptomycin 500mg vials due to possible particulate matter. This could cause serious injury if injected. Affected vials have specific lot numbers and expiration dates.

🇺🇸 FDA recall #D-1484-2020DrugMylan ›
Take action

Contact the company

Recalling firmMylan Institutional LLC4901 Hiawatha Dr · Rockford, IL 61103-1287
✎ GovInfoNow plain-language explainer

Mylan is recalling Daptomycin for Injection vials that may contain particulate matter. This could cause serious injury if injected into the body. The recall affects specific vials with lot number 7605112 and expiration date 10/2021. Read more at govinfonow.com/recall/36952-mylan-daptomycin-injection-recall-particulate-matter-hazard.

Source Summary by GovInfoNow · govinfonow.com/recall/36952-mylan-daptomycin-injection-recall-particulate-matter-hazard · Updated October 5, 2026 · FDA enforcement record: FDA #D-1484-2020

Cite this page

“Mylan Daptomycin Injection Recall: Particulate Matter Hazard.” GovInfoNow, updated October 5, 2026. https://govinfonow.com/recall/36952-mylan-daptomycin-injection-recall-particulate-matter-hazard. Based on FDA recall #D-1484-2020 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1484-2020%22&limit=1).

The Food and Drug Administration announced on July 7, 2020, that Mylan Institutional LLC is recalling Daptomycin for Injection due to the presence of particulate matter. The agency issued recall number D-1484-2020 for the Class I voluntary recall.

How to tell if you have it

  • Brand: Mylan
  • Product: Daptomycin for Injection, 500 mg/vial, Single-Dose Vial
  • NDC: 67457-813-50
  • Lot #: 7605112
  • Expiration Date: 10/2021
  • Quantity: 18,480 vials
  • Distribution: USA Nationwide

The hazard

The recall addresses the presence of particulate matter in the sterile injection vials. The FDA classified this as a Class I hazard.

Context

GovInfoNow's records show Mylan Institutional LLC has conducted 10 other recalls since Jan. 23, 2015. Other recent recalls include a May 3, 2021 labeling error for Mylan Thiamine HCl Injection and an Aug. 17, 2020 label mix-up risk for Mylan Amiodarone Injection. Similar products have faced issues such as the July 2, 2026 precipitate risk in Mylan Mycophenolate Mofetil Injection and particulate matter hazards in B. Braun Medical's April 28, 2026 Lactated Ringer's Injection recall.

How to tell if you have this one

Check for lot number 7605112 on the vial label with expiration date 10/2021. The product is a 500 mg/vial single-dose injection for prescription use only.

  • Brand
    Mylan
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Check Vial Label

    Look for lot number 7605112 and expiration date 10/2021 on the vial label.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “USA Nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA terminated this recall 2.6 years after the firm started it.

1. Firm started the recall: Jul 7, 202012. FDA classified it Class I: Aug 4, 202023. Published in FDA’s Enforcement Report: Aug 12, 202034. FDA terminated the recall: Jan 27, 2023420202023
  1. Firm started the recall
  2. FDA classified it Class I
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-1484-2020 (July 7, 2020) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1484-2020 to see it in context.
  • Plain-language summary written by qwen3:4b on October 5, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA